Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA OKs Use Of “Bone Black” In Cosmetics, Gives One Month For Objections

This article was originally published in The Rose Sheet

Executive Summary

"Bone black" will be permitted for use starting July 18 as a color additive in eyeliner, eye shadow, mascara and face powder in the absence of stakeholder objections, according to an FDA notice published June 18 in the Federal Register

You may also be interested in...



In Brief: Color additive petition

Color additive petition: Melvindale, MI-based Ebonex files a petition with FDA requesting that bone black be approved as a color additive for use in cosmetics, including cosmetics used in the eye area, according to a Sept. 1 Federal Register notice. In the environmental assessment portion of the firm's submission, Ebonex said that the pigment, which is made by carbonizing bones, has been determined by NTP-IARC to be non-carcinogenic. In addition, the submission states, "FDA regards bone black as GRAS" (generally recognized as safe) for contact with food. According to Ebonex, the pigment is currently used in various products including paints, plastics and crayons for children. The firm describes bone black as a "niche black," explaining that the pigment, which has low oil absorption, provides a flat, non-glossy, matte color...

Unilever’s Dove Recommits To ‘Real Women’ Against Rising AI Threat

Unilever PLC’s Dove and Baby Dove brands continue tackling prominent social causes with a vow to be responsible about representing women realistically in advertising in the age of AI and a renewed commitment to closing the Black maternal care gap.

L’Oreal Joins J&J And Major Retailers Defending Benzene Class Actions In Federal Courts

Benzoyl peroxide-based acne drug products and their alleged proclivity to become contaminated with carcinogenic benzene are at the center of putative class actions filing against L’Oreal in federal courts around the US.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS014799

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel